Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): A potential new therapy

TheScientificWorldJournal

Volumn 8, Issue , 2008, Pages 1325-1327

  Fusi, L ^a   Purohit, A ^b   Brosens, J ^a   Woo, L W L ^c   Potter, B V L ^c   Reed, M J ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BATH   (United Kingdom)

Author keywords

667Coumate; Endometriosis; Steroid sulfatase; Steroid sulfatase inhibitors; STX64

Indexed keywords

AROMATASE; BN 83495; SEX HORMONE ANTAGONIST; STERYL SULFATASE; STX 64; UNCLASSIFIED DRUG;

DRUG EFFICACY; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; REVIEW; SYMPTOMATOLOGY;

ADULT; COUMARINS; DISEASE PROGRESSION; ENDOMETRIOSIS; ENZYME INHIBITORS; ESTROGENS; FEMALE; HUMANS; OVARY; STERYL-SULFATASE; SULFONAMIDES; SULFONIC ACIDS; TREATMENT OUTCOME;

EID: 58449118553     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2008.164     Document Type: Review

References (18)

1. Vigano, P., Parazzini, F., Somigliana, E., and Vercellini, P. (2004) Endometriosis: epidemiology and aetiological factors. Best Practice Res. Clin. Obstet. Gynaecol. 18, 177-200.
2. Sampson, J.A. (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am. J. Obstet. Gynecol. 14, 422-425.
3. Nap, A., Groothuis, P.G., Demir, A.Y., Evers, J.L.H., and Dunselman, G.A.J. (2004) Pathogenesis of endometriosis. Best Practice Res. Clin. Obstet. Gynaecol. 18, 233-244.
4. Halme, I., White, C., Kauma, S., Estes, J., and Haskill, S. (1988) Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro. J. Clin. Endocrinol. Metab. 66, 1044-1049.
5. Purohit, A., Fusi, L., Brosens, J., Woo, L.W.L., Potter, B.V.L., and Reed, M.J. (2008) Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy. Hum. Reprod. 23, 290-297.
6. Noble, L.S., Simpson, E.R., Johns, A., and Bulun, S.E. (1996) Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 81, 174-179.
7. Noble, L.S., Takayama, K., Zeitoun, K.M., Putman, J.M., Johns, D.A., Hinselwood, M.M., Agarwal, V.R., Zhao, Y., Carr, B.R., and Bulun, S.E. (1997) Prostaglandin E2 stimulates aromatase expression in endometriosis derived stromal cells. J. Clin. Endocrinol. Metab. 82, 600-602.
8. Bulun, S.E., Zeitoun, K.M., Takayama, K., Simpson, E.R., and Sasano, H. (2000) Aromatase as a therapeutic agent in endometriosis. Trends Endocrinol. Metab. 11, 22-27.
9. Takayama, K., Zeitoun, K., Gunby, R.T., Sasano, H., Carr, B.R., and Bulun, S.E. (1998) Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil. Steril. 69, 709-713.
10. Reed, M.J., Purohit, A., Woo, L.W.L., Newman, S.P., and Potter, B.V.L. (2005) Steroid sulphatase: molecular biology, regulation, and inhibition. Endocr. Rev. 26, 171-202.
11. Smuc, T., Pucely, M.R., Sinkovec, J., Husen, B., Thole, H., and Rizner, T.L. (2007) Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol. Endocrinol. 23, 105-111.
12. Zeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Anderson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) Deficient 17β-hydroxysteroid dehydrogenase Type 2 expression in endometriosis: failure to metabolize 17β estradiol. J. Clin. Endocrinol. Metab. 83, 4474-4480.
13. Purohit, A., Wang, D.Y., Ghilchik, M.W., and Reed, M.J. (1996) Regulation of aromatase and sulphatase in breast cancer cells. J. Endocrinol. 150(Suppl.), S56-S71.
14. Reed, M.J. and Purohit, A. (1997) Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr. Rev. 18, 701-715.
15. Woo, L.W.L., Purohit, A., Reed, M.J., and Potter, B.V.L. (1996) Active site-directed inhibition of estrone sulphatase by non-steroidal coumarin sulphamates. J. Med. Chem. 39, 1349-1351.
16. Woo, L.W.L., Purohit, A., Malini, B., Reed, M.J., and Potter, B.V.L. (2000) Potent active site-directed inhibitors of steroid sulphatase by tryciclic coumarin-base sulphamates. Chem. Biol. 7, 773-791.
17. Stanway, S.J., Purohit, A., Woo, L.W.L., et al. (2006) Phase I study of STX64 (667 COUMATE) in breast cancer patients: the first study of a steroid sulphatase inhibitor. Clin. Cancer Res. 12, 1585-1592.
18. (1985) Revised American Fertility Society classification for endometriosis. Fertil. Steril. 43, 351-352.